210 related articles for article (PubMed ID: 29625700)
1. Quality of Life in Cushing's disease: A long term issue?
Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E
Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700
[TBL] [Abstract][Full Text] [Related]
2. Cushing's disease: the burden of illness.
Pivonello R; De Martino MC; De Leo M; Simeoli C; Colao A
Endocrine; 2017 Apr; 56(1):10-18. PubMed ID: 27189147
[TBL] [Abstract][Full Text] [Related]
3. Subtle cognitive impairments in patients with long-term cure of Cushing's disease.
Tiemensma J; Kokshoorn NE; Biermasz NR; Keijser BJ; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
J Clin Endocrinol Metab; 2010 Jun; 95(6):2699-714. PubMed ID: 20371667
[TBL] [Abstract][Full Text] [Related]
4. Quality of life impairment after a diagnosis of Cushing's syndrome.
Webb SM; Valassi E
Pituitary; 2022 Oct; 25(5):768-771. PubMed ID: 35767164
[TBL] [Abstract][Full Text] [Related]
5. Health-related Quality of Life in Patients After Treatment of Cushing's Disease.
Nader S; Burkhardt T; Vettorazzi E; Milian M; Aberle J; Petersenn S; Flitsch J
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):187-91. PubMed ID: 27008635
[TBL] [Abstract][Full Text] [Related]
6. Bilateral adrenalectomy in Cushing's disease: Altered long-term quality of life compared to other treatment options.
Sarkis P; Rabilloud M; Lifante JC; Siamand A; Jouanneau E; Gay E; Chaffanjon P; Chabre O; Raverot G
Ann Endocrinol (Paris); 2019 Feb; 80(1):32-37. PubMed ID: 30243473
[TBL] [Abstract][Full Text] [Related]
7. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
[TBL] [Abstract][Full Text] [Related]
9. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in Cushing's syndrome.
Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
[TBL] [Abstract][Full Text] [Related]
11. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in patients after long-term biochemical cure of Cushing's disease.
van Aken MO; Pereira AM; Biermasz NR; van Thiel SW; Hoftijzer HC; Smit JW; Roelfsema F; Lamberts SW; Romijn JA
J Clin Endocrinol Metab; 2005 Jun; 90(6):3279-86. PubMed ID: 15741267
[TBL] [Abstract][Full Text] [Related]
13. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
[TBL] [Abstract][Full Text] [Related]
14. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O
Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
16. Cushing's disease in 2012.
Obiols Alfonso G; Biagetti Biagetti B; Chacón Oreja A; Salvador Rodríguez J
Endocrinol Nutr; 2014 Feb; 61(2):93-9. PubMed ID: 24041670
[TBL] [Abstract][Full Text] [Related]
17. Comorbidities in Cushing's disease.
Sharma ST; Nieman LK; Feelders RA
Pituitary; 2015 Apr; 18(2):188-94. PubMed ID: 25724314
[TBL] [Abstract][Full Text] [Related]
18. Cushing's disease.
De Martin M; Pecori Giraldi F; Cavagnini F
Pituitary; 2006; 9(4):279-87. PubMed ID: 17077950
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
20. Cushing's disease.
Tritos NA; Biller BM
Handb Clin Neurol; 2014; 124():221-34. PubMed ID: 25248590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
